Do you have a spare $5,000 to invest but aren't sure where to put it? Here are four ASX 200 shares I have my eye on this week, and they're all tipped to climb higher this year.
Image source: Getty Images
Cochlear Ltd (ASX: COH)
Cochlear shares crashed in April after the ASX healthcare company downgraded its FY26 earnings guidance, citing weaker conditions across developed markets and softer demand. At the time of writing, the shares have climbed 1% since reaching a multi-year low. There is a long way for the stock to recover back to pre-crash levels but I think there is potential for a rebound. The guidance downgrade followed the ASX 200 company's softer-than-expected half-year result earlier this year, and a sector-wide rotation away from ASX healthcare shares. Brokers aren't deterred, though. They still rate the stock as a buy and are tipping a potential 127% upside to $219.06, at the time of writing.
National Australia Bank Ltd (ASX: NAB)
Concerns about global volatility, higher interest rates, and a slowdown in lending have taken their toll on NAB shares this year. Further fears about rising climbing loan arrears, housing-market policy changes, and slower economic growth have also dampened ASX bank shares across the board. But I think the share price is now close to the bottom, and we could start to see a rebound; sentiment is also looking to be starting to shift. Just last week, some analysts revised their outlook on the stock. Brokers tip the ASX 200 bank stock to climb 8% higher to $39.40 a piece, at the time of writing.
Flight Centre Travel Group Ltd (ASX: FLT)
Flight Centre shares have collapsed 37% since peaking at a 52-week high in January this year. But the company reported a strong third-quarter update earlier this month, despite ongoing travel disruptions and fuel supply challenges. The ASX 200 travel share said its underlying profit before tax (UPBT) has risen 9.7% and its total transaction value is up 7.6% for the nine months to 31 March. Not only that, Flight Centre confirmed that its costs are now well below pre-pandemic levels, productivity is up across the business, and the company is on track to reach its full-year UPBT target of $315 million to $350 million. Brokers tip the stock to climb 57% to $16.19, at the time of writing.
Ampol Ltd (ASX: ALD)
At the time of writing, Ampol shares are just 2% below a two-year high recorded earlier this month. The ASX 200 fuel company's shares rocketed higher on the back of conflict in the Middle East and concerns about global oil supply. The company has also posted a couple of good news announcements recently. In April, the Aussie fuel supplier said it had submitted a formal remedy offer to the Australian Competition and Consumer Commission (ACCC) about a proposed acquisition of fuel and convenience store operator EG Australia. The company also confirmed a 10% increase in refinery production, higher refiner margins, and increased production in its Q1 FY26 trading update. Ampol has locked in diesel and jet fuel supply through to the end of May, and gasoline supplies to the end of June, despite rising landed crude costs. Brokers tip a 3% upside to $36.16 over the next 12 months.
